Navigation Links
NSF International Offers Answers to Rising Toy Safety Concerns
Date:12/4/2008

NSF Toy Safety Program Offers Manufacturers A Way to Improve Toy Safety by Meeting the Requirements from the NewConsumer Product Safety Improvement Act

ANN ARBOR, Mich., Dec. 4 /PRNewswire-USNewswire/ -- Recent toy recalls continue to generate concerns among consumers about the safety of their children's toys, reinforcing the importance of toy testing. The NSF Toy Safety team offers a solution -- integrated services that include auditing, testing and assessment. This team of toy safety experts is available to answer questions about toy safety.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070816/DCTH039LOGO)

WHAT: To help assure that safer toys are making their way to U.S. consumers, lawmakers introduced the Consumer Product Safety Improvement Act (CPSIA), which was signed into law on August 14, 2008 by President Bush. The new act includes requirements for lead and a ban on certain phthalates in products designed for children 12 and younger. It also requires mandatory third-party testing and labeling requirements for all toys and children's products sold in the U.S. NSF International can perform testing required by the new legislation to assist toy manufacturers in meeting the CPSIA requirements.

WHY: Recalls of products intended for children continue to be alarming. Children's products, including toys, nursery products and clothing, accounted for two-thirds (nearly 29 million) of all products being recalled from 2007-08. More recalls were issued for lead than for any other hazard. In fact, there were 121 recalls announced for more than 12.2 million lead-laden products. Almost all of the lead recalls were for toys and other products intended for children.(1)

WHEN: The CPSIA will incorporate increasing levels of regulation with the first deadline regarding lead in paint and surface coatings set for December 21, 2008. Several other requirements for toys will take affect in 2009 when third party testing will be required for assessing lead in the substrate material, phthalates, physical, and mechanical testing.

WHO: By law, all manufacturers who wish to selltoys in the U.S. in 2009 must have their toys tested by anaccredited third-party testing lab. Companies that fail to meet the new requirements are subject to civil and criminal penalties including a $100,000 penalty per violation and up to five years imprisonment.

Background on the NSF Toy Safety Program

The NSF Toy Safety program tests a product and its materials for several aspects of toy safety including heavy metal testing (lead and others), mechanical and physical safety, flammability, chemical composition, phthalate content and electrical safety.

For more information, please contact Dave Parzen, Technical Manager of Toy Safety, at 734.827.6859 or parzen@nsf.org or visit www.playsafer.org for more information on the new legislation.

To view the entire news release with photo, please visit http://www.nsf.org/info/press/index.asp?p_id=16385.

(1)Consumers Union's Still Not Safe Report, 12/2/2008 -- report based on the number of product recalls publicly announced by the U.S. Consumer Product Safety Commission from October 1, 2007 through September 30, 2008.

    CONTACT: Greta Houlahan
    Phone: 734-913-5723
    Email: houlahan@nsf.org


'/>"/>
SOURCE NSF International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Kentucky - Cincinnati, Ohio (PRWEB) , ... December ... ... in the production of miniature, folded, pharmaceutical inserts and outserts. As a ... Serialization Device. This addition will enable Flottman to individually code professional inserts ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... An inventor ... amputees to safely ride all types of amusement park rides. , The patent-pending SAFETY ... unit is easy to use and could be set up in a matter of ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to ... "I thought that if the nebulizer had a more child-friendly design, then children would ... He developed the patent-pending NEBY to avoid the need to deliver medication via a ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company ... severe, rare diseases, today announced that senior management will participate in ... Conference at the InterContinental Barclay Hotel in New York ... ET. About aTyr Pharma ... aTyr Pharma is engaged in the ...
(Date:12/9/2016)... Dec. 9, 2016  Axovant Sciences Ltd. (NYSE: ... company focused on the treatment of dementia, today ... a Phase 2b trial evaluating treatment with intepirdine ... with donepezil plus placebo in people with mild-to-moderate ... of intepirdine to treatment was associated with reduced ...
(Date:12/8/2016)... 8, 2016 Australia Glaucoma Surgery Devices ... new report, "Australia Glaucoma Surgery Devices Market Outlook ... Australia Glaucoma Surgery Devices market. The report provides ... units) and average prices (USD) within market segement ... provides company shares and distribution shares data for ...
Breaking Medicine Technology: